ArticlePLOS global public health2025
Disparities in chronic ischemic heart disease-related mortality across sex, race, and urbanization status in the United States, 1999-2019.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Trends and disparities in chronic ischemic heart disease mortality among adult cancer patients: a nationwide CDC WONDER analysis (1999-2020).Cardio-oncology (London, England) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic ischemic heart disease (CIHD) is one of the leading causes of significant morbidity and mortality in the United States. While previous studies have reported an overall decline in ischemic heart disease mortality, contemporary trends in CIHD-related mortality across sex, race, and urbanization status remain inadequately explored. We examined CIHD-related mortality trends in the U.S. from 1999 to 2019.We analyzed mortality data from the CDC WONDER database using CIHD ICD-10 codes. Age-adjusted mortality rates (AAMR) were calculated per 100,000 individuals. Trends were analyzed using Joinpoint regression to determine annual percentage change (APC) and average annual percentage change (AAPC) with 95% confidence intervals. Over two decades, 5,729,619 CIHD-related deaths were recorded. AAMR declined from 185.6 (95% CI: 184.9-186.2) per 100,000 in 1999 to 94.9 (95% CI: 94.5-95.3) per 100,000 in 2019. There were, however, disparities among demographic groups. Males had consistently higher mortality than females (overall AAMR: 167.2 vs. 96.0 per 100,000), and among racial groups, non-Hispanic Black individuals had the highest AAMR (148.3 per 100,000. Initially, urban areas had higher mortality than rural areas, but by 2019, their AAMRs converged (urban: 94.7 [95% CI: 94.3-95.1]; rural: 96.1 [95% CI: 95.1-97.0] per 100,000). CIHD mortality has declined across all demographics over the last two decades; however, disparities persist, particularly among males and non-Hispanic Black individuals. While rural and urban populations had differing mortality rates initially, they showed similar AAMR by the end of the study period. Focused public health interventions are crucial to addressing these inequities.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.